# Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension

> **NCT00759551** · PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 555 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Azilsartan
- **DRUG:** Azilsartan
- **DRUG:** Azilsartan
- **DRUG:** Azilsartan
- **DRUG:** Azilsartan
- **DRUG:** Placebo
- **DRUG:** Olmesartan

## Key facts

- **NCT ID:** NCT00759551
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** 555 (ACTUAL)
- **Last updated:** 2010-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00759551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00759551, "Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00759551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*